Senior investor focused on growth-stage technology and telecommunications companies, combining operating insight with deal execution and portfolio governance. Michael Behner is known for sourcing cross-border transactions, structuring minority and control investments, and driving revenue and go-to-market expansion at scale. Prior roles span operating and investment functions in PE and strategic corporate development, with experience working alongside founders and management teams. Regularly participates in board oversight, capital raises and exit planning for venture-to-buyout opportunities.
Senior investor focused on growth-stage technology and telecommunications companies, combining operating insight with deal execution and portfolio governance. Michael Behner is known for sourcing cross-border transactions, structuring minority and control investments, and driving revenue and go-to-market expansion at scale. Prior roles span operating and investment functions in PE and strategic corporate development, with experience working alongside founders and management teams. Regularly participates in board oversight, capital raises and exit planning for venture-to-buyout opportunities.
Combines a growth-stage technology and telecommunications focus with a pragmatic operating-investor approach. Emphasizes scalable revenue models, repeatable go-to-market playbooks and unit-economics-led growth; targets minority and control positions in cross-border situations where operational guidance accelerates commercialization. Capital allocation favors durable market-share gains, founder-aligned governance and staged value creation through commercial scaling, M&A tuck-ins and disciplined exit planning. Risk is managed via active board oversight, milestone-conditioned capital tranches and a focus on margin expansion before leverage.
Combines a growth-stage technology and telecommunications focus with a pragmatic operating-investor approach. Emphasizes scalable revenue models, repeatable go-to-market playbooks and unit-economics-led growth; targets minority and control positions in cross-border situations where operational guidance accelerates commercialization. Capital allocation favors durable market-share gains, founder-aligned governance and staged value creation through commercial scaling, M&A tuck-ins and disciplined exit planning. Risk is managed via active board oversight, milestone-conditioned capital tranches and a focus on margin expansion before leverage.
| Trades 902 | Longs Won 607/902 67% | Profit Factor 5.17 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $172,659.36 |
| Average Win $59,646.28 | Best Trade (Aug 05) $3.59M | Sharpe Ratio -10.47 |
| Average Loss -$23,719.17 | Worst Trade (Aug 02) -$917,710.53 | Z-Score 8.51 (100%) |
| Commissions $0 | Avg. Trade Length 10m 3w | Expectancy $32,389.03 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,299 | 6,569 | 5,839 | 5,109 | 4,380 | 3,650 | 2,920 | 2,190 | 1,460 | 730 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 26,627 | $6.66M | $8.23M | - | $1.56M | 23.48% | -7.354% |
ABBV AbbVie Inc. | 7,491 | $1.36M | $1.88M | - | $523,074.35 | 38.55% | -2.513% |
ABT Abbott Laboratories | 6,589 | $745,415.15 | $696,457.3 | - | -$48,957.85 | -6.57% | +0.085% |
ADP Automatic Data Processing Inc. | 3,426 | $1M | $912,891.93 | - | -$89,958.47 | -8.97% | +0.982% |
AMAT Applied Materials, Inc. | 4,929 | $801,560.69 | $2.5M | - | $1.7M | 212.18% | +1.176% |
AMCR Amcor plc | 6,220 | $247,245 | $279,153.6 | - | $31,908.6 | 12.91% | -0.598% |
AMD Advanced Micro Devices, Inc. | 2,886 | $349,704.87 | $1.37M | - | $1.02M | 292.95% | -1.904% |
AMGN Amgen Inc. | 2,048 | $540,565.18 | $788,807.68 | - | $248,242.5 | 45.92% | -0.64% |
AMZN Amazon.com Inc | 34,482 | $7.58M | $9.36M | - | $1.78M | 23.53% | +15.321% |
APH Amphenol Corporation | 2,640 | $232,742.4 | $212,124 | - | -$20,618.4 | -8.86% | +0.551% |
ASML ASML Holding N.V. New York Registry Shares | 623 | $437,793.81 | $1.01M | - | $577,073.19 | 131.81% | -1.359% |
AVGO Broadcom Inc. | 1,686 | $395,283.22 | $656,326.08 | - | $261,042.86 | 66.04% | +0.371% |
AXP American Express Company | 720 | $218,715.91 | $242,100 | - | $23,384.09 | 10.69% | -0.376% |
B BARRICK MINING CORP Common Stock (ABR0) | 11,310 | $403,430.29 | $415,416.3 | - | $11,986.01 | 2.97% | -2.573% |
BDX Becton, Dickinson and Company | 3,651 | $548,746.03 | $604,678.62 | - | $55,932.59 | 10.19% | +0.103% |
BLK BlackRock, Inc. | 260 | $266,528.89 | $283,501.4 | - | $16,972.51 | 6.37% | -0.727% |
BMY Bristol-Myers Squibb Company | 12,345 | $703,023.5 | $806,251.95 | - | $103,228.45 | 14.68% | +0.694% |
BRK-B Berkshire Hathaway Inc. | 3,029 | $1.52M | $1.55M | - | $27,896.8 | 1.83% | +0.365% |
BSCR Invesco BulletShares 2027 Corporate Bond ETF | 11,516 | $226,002 | $225,771.18 | - | -$230.82 | -0.1% | 0.0 |
BSJR Invesco Bulletshares 2027 High Yield Fund | 10,101 | $225,909 | $225,555.33 | - | -$353.67 | -0.16% | +0.022% |